Tumor microenvironment as a therapeutic target in cancer

Pharmacol Ther. 2021 May:221:107753. doi: 10.1016/j.pharmthera.2020.107753. Epub 2020 Nov 28.

Abstract

Tumor microenvironment denotes the non-cancerous cells and components presented in the tumor, including molecules produced and released by them. The constant interactions between tumor cells and the tumor microenvironment play decisive roles in tumor initiation, progression, metastasis, and response to therapies. The tumor microenvironment as a therapeutic target in cancer has attracted great research and clinical interest. Here we summarize the current progress in targeting the tumor microenvironment in both drug development and clinical trials; highlight challenges in targeting the tumor microenvironment to achieve therapeutic efficacy; explore new technologies and approaches to better decipher the tumor microenvironment; and discuss strategies to intervene in the pro-tumor microenvironment and maximize therapeutic benefits.

Keywords: Drug; Resistance; Target; Therapy; Tumor microenvironment.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Cell Transformation, Neoplastic
  • Clinical Trials as Topic
  • Drug Development
  • Humans
  • Neoplasms* / drug therapy
  • Tumor Microenvironment* / drug effects

Substances

  • Antineoplastic Agents